NCT06872086Not yet recruiting
Assessment of Blood Indices in Systemic Lupus Erythematosus
Assessment of Blood Indices As Predictors of Disease Activity in Systemic Lupus Erythematosus
Source: ClinicalTrials.gov · Last updated 12 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This case-control study aims to explore the relationship between specific blood indices (lymphocyte-monocyte ratio, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammatory index) and disease activity in patients with systemic lupus erythematosus (SLE). The study includes 70 SLE patients and 70 healthy controls, matched for age and gender, recruited from Assiut University Hospital. Disease activity is assessed using the SLEDAI-2K score, and blood indices are analyzed to determine correlations with disease activity.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 70 (estimated)
- First submitted
- 7 Mar 2025
- Start date
- 1 May 2025
- Primary completion date
- 30 Aug 2026
- Lead sponsor
- Assiut University
- Diseases
- Lupus (SLE)
- NCT number
- NCT06872086
What you commit to
- Study type: Observational
- Planned participants: 70
- From 1 May 2025 to the primary completion date, 30 Aug 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Patients with other autoimmune diseases (e.g., rheumatoid arthritis, Sjögren's syndrome).
- Recent infections or acute inflammatory conditions.
- Individuals with hematological disorders unrelated to SLE (e.g., leukemia, lymphoma).
Who the study is looking for
- Patients aged 18 years or older diagnosed with SLE according to the 2019 ACR/EULAR classification criteria.
- Healthy controls without any autoimmune diseases or significant comorbidities
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.